Patent application number | Description | Published |
20080214985 | Active transdermal medicament patch - An active transdermal medicament patch includes a planar substrate with a therapeutic face releasably retainable against the skin of a patient. A return electrode and a medicament matrix susceptible to permeation by medicament are secured at separated locations on the therapeutic face. Each electrically conductively engages the skin, when the substrate is retained thereon. A power source carried on the substrate is electrically coupled between the medicament matrix and a programmed microprocessor also carried on the substrate. A substantially invariant voltage presented at an output contact of the microprocessor is applied during a predetermined therapy period across the skin between the medicament matrix and the return electrode, inducing transcutaneous migration of medicament into the skin at a substantially constant rate. A light-emitting diode carried on the substrate and coupled to the microprocessor communicates that the patch is operating. | 09-04-2008 |
20080305154 | Transdermal medicament patch and active electrode for same - A transdermal medicament patch includes a biocompatible substrate having a therapeutic face on one side configured for disposition against the skin of a patient, a biocompatible adhesive on the therapeutic face, a planar medicament matrix covering a portion of the therapeutic face, and a release liner covering the portion of therapeutic that is not obscured by the medicament matrix. An aperture formed through the release sheet affords direct access by medicament to the entire surface of the medicament matrix opposite from the therapeutic face of the substrate. An active electrode positioned between the medicament matrix and the therapeutic face of the substrate includes an electrically conductive backing layer positioned against the therapeutic face of the substrate and a pH-control layer covering less than all of the side of the backing layer opposite from the therapeutic face of the substrate. One active electrode design criterion relates the relative size of the pH-control layer to the size of the backing layer; another relates the size of portion of the area of the backing layer that is free of the pH-control lawyer to the size of the pH-control layer. The pH-control layer is made of an electrically conductive material capable of moderating changes in the hydrogen-ion concentration in the medicament matrix during iontophoretic current flow. An electrical contact electrically coupled through the substrate to the backing layer includes a hollow, electrically conductive snap fitting having an open end and a cooperating stud that is inserted into the open end of the snap. | 12-11-2008 |
20090186072 | Operational status for active transdermal medicament patch - An active transdermal medicament patch includes a planar substrate with a therapeutic face releasably retainable against the skin of a patient. A return electrode and a medicament matrix susceptible to permeation by medicament are secured at separated locations on the therapeutic face and electrically conductively engage the skin. A detector monitors iontophoretic medicament migration into the skin. An integrator operating on the output of the detector produces a running cumulative total of the amount of medicament delivered during a plurality of temporally non-contiguous therapy subsessions. A circuit breaker terminates medicament migration, when the output of the integrator equals a predetermined medicament quantity. A timer active during medicament migration stimulates a driver to operate a light-emitting diode in a distinct delivery confirmation mode during each a sequence of non-overlapping predetermined therapy subsessions, respectively. A circuit board on the substrate in a compact, folded state bears interconnected electrical circuit components. | 07-23-2009 |
20110160639 | COSMETIC IONTOPHORESIS SYSTEM - Iontophoretically administering a cosmetic agent requires an active electrode and a return electrode secured to the skin ( | 06-30-2011 |
20110160640 | Operation management of active transdermal medicament patch - A transdermal medicament patch includes a flexible substrate having a therapeutic face configured for releasable retention against the skin of a patient, a medicament matrix susceptible to permeation by medicament and secured to the therapeutic face of the substrate, and a return electrode secured to the therapeutic face spaced from the medicament matrix. The return electrode and the medicament matrix effect electrically conductive engagement with the skin of the patient when the substrate is retained thereupon. A power source is carried on substrate so electrically coupled between the medicament matrix and the return electrode as to cause iontophoretic migration of medicament from the medicament matrix into the skin of the patient. A dosage control circuit carried non-removably on said substrate limits to a predetermined medicament quantity the total medicament administered into the skin of the patient by iontophoretic migration during a predetermined therapy period. | 06-30-2011 |
20140316505 | ELECTRODE FOR USE WITH TRANSCRANIAL DIRECT CURRENT STIMULATION - The present invention is directed to signing up at a single site to receive both credit and business information, and the combining of personal credit information for an individual and business credit information of a business with which the individual is associated. For example, the invention can provide a website where a user can lrequest to view an individual's personal credit information and the business credit information of a business that the individual owns. In this manner, the user can quickly and easily obtain a more complete view of the financial status of an individual or a business in a single location. | 10-23-2014 |
20150025441 | Active Transdermal Medicament Patch and Circuit Board for Same - An active transdermal medicament patch includes a planar substrate with a therapeutic face releasably retainable against the skin of a patient. A return electrode and a medicament matrix susceptible to permeation by medicament are secured at separated locations on the therapeutic face and electrically conductively engage the skin. A detector monitors iontophoretic medicament migration into the skin. An integrator operating on the output of the detector produces a running cumulative total of the amount of medicament delivered during a plurality of temporally non-contiguous therapy subsessions. A circuit breaker terminates medicament migration, when the output of the integrator equals a predetermined medicament quantity. A timer active during medicament migration stimulates a driver to operate a light-emitting diode in a distinct delivery confirmation mode during each a sequence of non-overlapping predetermined therapy subsessions, respectively. A circuit board on the substrate in a compact, folded state bears interconnected electrical circuit components. | 01-22-2015 |
Patent application number | Description | Published |
20090047312 | Microgel and external compositions containing the same - The present invention provides a microgel having a mean particle size of 0.1-1,000 μm, the microgel being produced from a gel which is formed by use of a hydrophilic compound capable of forming a gel. An external composition containing the microgel provides an excellent sensation during use; i.e., the composition provides neither sticky sensation during use nor frictional sensation. Furthermore, even when a large amount of a pharmaceutical ingredient, such as a whitening ingredient, or a salt is incorporated into the composition, the viscosity of the composition is not lowered, and the composition exhibits excellent viscosity increasing property. In addition, the composition exhibits long-term stability, without inviting separation of water. | 02-19-2009 |
20100029787 | Thickener, Cosmetic Preparation Containing The Same, And Process For Producing The Same - The present invention is a thickener consisting of a microgel obtained by radical polymerization of water soluble ethylene-type unsaturated monomers dissolved in the dispersion phase in a composition having an organic solvent or an oil component as the dispersion medium and water as the dispersion phase, as well as a cosmetic containing said thickener. | 02-04-2010 |
20110165323 | Production method of dry water - A production method of dry water containing an aqueous ingredient coated with a hydrophobic powder to form a powder state capable of liquefying upon embrocation at the time of use, wherein the dry water is produced by charging a hydrophobic powder and an aqueous ingredient into a hollow container forming a hydrophobic enclosed space in the inside thereof, followed by agitating at a high speed in the enclosed hydrophobic hollow container to form the aqueous ingredient to fine aqueous droplets, and then allowing the surfaces of the fine aqueous droplets to be uniformly adsorbed with the hydrophobic powder, whereby the dry water in the form of a powder state, but is capable of being liquefied upon embrocation at the time of use to be simply produced in a large scale. | 07-07-2011 |